EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
Compliance to Competitive Advantage in Pharma Supply
Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser
Advisory Board
KNOWLEDGE BANK
-
Articles
Precision Oncology Trials: Navigating the Future of Cancer Care
Precision oncology is revolutionizing cancer care offering targeted treatments tailored to each patients unique genetic makeup As we navigate the future of cancer care precision oncology trials are paving the way for more effective and personalized treatment options
Achieving Full Digital Maturity in Pharma Manufacturing: A Paperless Transformation Guide
The pharmaceutical sector is changing radically as manufacturers do not rely on the past and dataintensive processes The vision of paperless pharma manufacturing is not a dream anymore it is a strategy based on the pressure of the regulators the complexity of operations and the need to accomplish faster and with accuracy production The center of this change is the digital pharma manufacturing and...
Sustainable Pharma Manufacturing: Eco-Friendly Practices for the Pharmaceutical Industry
The pharmaceutical business is of significant importance to the healthcare sector all over the world yet it is also among the manufacturing industries that are resourceconsuming Energyintensive production processes complicated chemical synthesis and mass packaging processes have all contributed to pollution and emissions of carbon emissions to the environment as part of the traditional drug manufa...
Building Resilient Pharma Supply Chains to Strengthen Patient Care
The failure to deliver a temperaturesensitive biologic or a critical maintenance drug on time is becoming a patient outcome crisis not just an operational inefficiency By fortifying our global logistics networks we proactively safeguard the availability of lifesaving therapies and essential healthcare supplies securing the healthcare industrys central promise to global health This strategic impera...
From Visibility to Decision Readiness: The Next Phase of Quality Maturity in Pharma
Over the past decade pharmaceutical organisations have made strong progress in both digitising and digitalising quality operations Systems such as laboratory information management systems LIMS manufacturing execution systems MES and electronic quality management systems eQMS have strengthened traceability embedded workflows and enabled real time visibility across quality processes
Navigating the EU Biosimilars Regulatory Terrain: A Comprehensive Overview
In the everevolving landscape of biological medicines biosimilars have emerged as a costeffective alternative to their reference products For market access in the European Union biosimilars must comply
-
Techno Trends
University of Queensland Researchers Unlock New Drug Target for Neurodegenerative Disease Therapies
University of Queensland UQ researchers have developed a novel drug molecule that targets the hardtostudy immune receptor CaR opening new possibilities for treatments targeting neurodegenerative diseases such as Motor Neurone Disease MND
-
Projects
Evonik Announces US$100 Million Modernization of U.S. Drug Substance CDMO Facility
Evonik has announced a US million investment to modernize its Tippecanoe Labs manufacturing site in Lafayette Indiana over the next five years The investment is aimed at strengthening the companys US drug substance
-
Research Insights
A genomic-led strategy to anticipate drug safety effects
Safetyrelated issues account for approximately of failures in new drug discovery programs On top of that many are discovered during postmarketing surveillance
-
whitepaper
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys
TOP ARTICLES
-
1
Achieving Full Digital Maturity in Pharma Manufacturing: A Paperless Transformation Guide
Kate Williamson
This article discusses how paperless pharma production is achieved to realize complete digital maturity, through automation, compliance-sourced software and integrated digital systems. It shows the ad...
-
2
Sustainable Pharma Manufacturing: Eco-Friendly Practices for the Pharmaceutical Industry
Kate Williamson
The goal of sustainable pharma production is the production processes that are greener and produce minimal impact on the environment without affecting the quality and compliance of produced drugs. Gre...
-
3
Building Resilient Pharma Supply Chains to Strengthen Patient Care
Lesley Barton
In the complex, global ecosystem of pharmaceutical manufacturing and distribution, the supply chain is no longer merely a logistical function but a direct extension of clinical efficacy. For C-level e...
-
4
From Visibility to Decision Readiness: The Next Phase of Quality Maturity in Pharma
Kavita Vengurlekar
Pharma companies can now see quality issues much earlier, thanks to digital systems. But faster visibility hasn’t always meant faster decisions. This article explains why the next step in qualit...
-
5
Navigating the EU Biosimilars Regulatory Terrain: A Comprehensive Overview
Kate Williamson
This comprehensive overview explores the EU biosimilars regulatory landscape, including key differences from generic drugs, the multi-step approval process, regulatory guidelines, market trends, chall...
press releases Read more...
FairJourney Bio Delivers Antibody Engineering for Novel Tumor-Conditional IL-12 Therapeutic Approach That Unlocks the Potential of Localized Cytokine Activation
FairJourney Bio FJBio a global antibody discovery expert today announced the publication of a peerreviewed study in mAbs describing a novel approach with the potential to improve the therapeutic window of IL
Ipsen completes acquisition of Kartos Therapeutics, strengthening late-stage Oncology pipeline
Ipsen announced today it has completed the acquisition of Kartos Therapeutics a clinicalstage biopharmaceutical company adding latestage MDM inhibitor navtemadlin in Phase III clinical development in myelofibrosis
Galen and POA Pharma unveil Galsana, a new global brand for rare metabolic diseases
At the SSIEM Annual Symposium in Helsinki Galen Ltd and POA Pharma announced the launch of Galsana a new global brand for their metabolic product portfolio bringing together established products
Infex Therapeutics to present new RESP-X Phase IIa data in late-breaking session at ERS Congress 2026
Infex Therapeutics a leading antiinfectives specialist today announced that new Phase IIa study data for RESPX INFEX its firstinclass antivirulence monoclonal antibody therapy in development for NCFB patients
Events Read more...
25 - 27
Aug 2026CPHI Korea 2026
COEX, Seoul, Korea
26 - 27
Aug 2026BIOMEDevice 2026
Boston Convention & Exhibition...
03 - 05
Sep 20265th MENA Congress for Rare Diseases 2026
Beach Rotana Hotel, Abu Dhabi,...
14 - 16
Sep 202614 - 15
Sep 202616th American DDF Summit
Omni Boston Hotel at the Seapo...
15 - 17
Sep 2026COPD Drug Development Summit 2026
Street, Boston, MA 02210, USA
21 - 23
Sep 2026Cell & Gene Therapy World Conference
Miami, Florida, USA
21 - 23
Sep 2026Cancer R&D World Conference
Hilton Garden Inn Miami Dolphi...
LATEST NEWS Read more...
Lupin and Tenpoint Therapeutics partner to commercialise YUVEZZI™ across European markets
Lupin Limited has announced that its wholly owned subsidiary VISUfarma BV has entered into an exclusive licensing agreement with Visus Therapeutics Inc a wholly owned subsidiary of Tenpoint Therapeutics Holding Limited
Rein Therapeutics receives US FDA Fast Track designation for LTI-03 in idiopathic pulmonary fibrosis
Rein Therapeutics has received Fast Track designation from the US Food and Drug Administration FDA for LTI an investigational treatment being developed for idiopathic pulmonary fibrosis IPF
IDEAYA Biosciences Announces Clinical Collaboration with Genentech for MTAP-Deleted, KRAS G12D-Mutant Pancreatic Cancer
IDEAYA Biosciences Inc NASDAQ IDYA has entered into a clinical collaboration with Genentech a member of the Roche Group to evaluate IDE in combination with GDC RG in patients
NTx Bio Supports Baylor College of Medicine in Manufacturing Personalised Cancer Vaccine for Phase 1 Melanoma Trial
NTx Bio is supporting Baylor College of Medicine in the manufacturing of a personalised cancer vaccine being evaluated in Diakonos Oncologys Phase trial for patients with refractory melanoma
VectorBuilder and Lir Therapeutics partner to advance AAV capsids for clinical development
VectorBuilder and Lir Therapeutics have entered into a strategic collaboration to develop adenoassociated virus AAV capsids that combine strong biological performance with the manufacturing and scalability requirements needed for clinical development
Cytovance Biologics launches standalone analytical services for biologics development
Cytovance Biologics has expanded its analytical services portfolio to provide standalone analytical support for biotechnology and pharmaceutical companies The new offering gives clients access to Cytovances analytical expertise and regulatoryready solutions without requiring a manufacturing engageme...









